Furthermore, DCC-2036 reduces macrophage infiltration [14, 15] and exhibits anti-angiogenic effects in breast cancer models [16], while it enhances survival in glioma models by inhibiting Tie-2 mediated pathways [15]. The gene discussed is TEK; the disease is breast carcinoma.